Back
Jazz Pharmaceuticals PLC 10K Form
Sell
48
JAZZ
Jazz Pharmaceuticals PLC
Last Price:
109.29
Seasonality Move:
24.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-08 | 10Q | JAZZ/Jazz Pharmaceuticals PLC Quarterly |
| 2023-08-09 | 10Q | JAZZ/Jazz Pharmaceuticals PLC Quarterly |
| 2023-05-10 | 10Q | JAZZ/Jazz Pharmaceuticals PLC Quarterly |
| 2022-11-09 | 10Q | JAZZ/Jazz Pharmaceuticals PLC Quarterly |
| 2022-08-03 | 10Q | JAZZ/Jazz Pharmaceuticals PLC Quarterly |
| 2022-05-04 | 10Q | JAZZ/Jazz Pharmaceuticals PLC Quarterly |
Receive JAZZ News And Ratings
See the #1 stock for the next 7 days that we like better than JAZZ
JAZZ Financial Statistics
Sales & Book Value
| Annual Sales: | $3.83B |
|---|---|
| Cash Flow: | $139.24M |
| Price / Cash Flow: | 7.36 |
| Annual Sales: | $60.03 |
| Price / Book: | 1.79 |
Profitability
| EPS (TTM): | 6.12000 |
|---|---|
| Net Income (TTM): | $414.83M |
| Gross Margin: | $3.4B |
| Return on Equity: | 12.08% |
| Return on Assets: | 3.72% |
Jazz Pharmaceuticals PLC Earnings Forecast
Key Jazz Pharmaceuticals PLC Financial Ratios
- The Gross Profit Margin over the past 19 years for JAZZ is 88.64%.
- The Selling, General & Administrative Expenses for JAZZ have been equal to 35.03% of Gross Profit Margin.
- The Research & Development expenses have been 22.16% of Revenue.
- The Interest Expense is 69.77% of Operating Income.
- The Net Earning history of JAZZ is 10.82% of Total Revenues.
- Per Share Earnings over the last 20 years have been positive in 12 years.
Jazz Pharmaceuticals PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | JAZZ |
| CUSIP: | G50871 |
| Website: | jazzpharmaceuticals.com |
Debt
| Debt-to-Equity Ratio: | 1.53 |
|---|---|
| Current Ratio: | 2.24 |
| Quick Ratio: | 1.52 |
Price-to-Earnings
| Trailing P/E Ratio: | 17.57 |
|---|---|
| Forward P/E Ratio: | 5.14 |
JAZZ Technical Analysis vs Fundamental Analysis
Sell
48
Jazz Pharmaceuticals PLC (JAZZ)
is a Sell
Is Jazz Pharmaceuticals PLC a Buy or a Sell?
-
Jazz Pharmaceuticals PLC stock is rated a Sell
The current Jazz Pharmaceuticals PLC [JAZZ] share price is $107.10. The Score for JAZZ is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.